Find and Pitch Jounalists, Get Your Story Covered

Tags: Camber Pharmaceuticals Generic Alesse Levonorgestrel and Ethinyl Estradiol Tablets Generic Zyloprim Allopurinol Tablets

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 6 days ago STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - 30 days ago STAT+: Pharmalittle: We’re reading about Amazon delivering Zepbound, hemophilia treatments, and more - 6 months ago STAT+: Pharmalittle: We’re reading about a failed schizophrenia drug trial, a Pfizer cancer drug, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Lilly Alzheimer’s drug adcomm, Amylyx ALS drug flop, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more - 7 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 7 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 7 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 9 months ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - 9 months ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - 10 months ago STAT+: Pharmalittle: Vertex and U.K. at odds over value of CF meds; French authorities probe Sanofi over alleged market manipulation - 11 months ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - 11 months ago STAT+: Lilly complains to the U.S. International Trade Commission about unapproved versions of Mounjaro - 11 months ago STAT+: Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit - 11 months ago
2	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	MHRA approves Astellas’ Vyloy combination for gastric cancer - 27 days ago
3	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Lilly’s Zepbound slashed risk of developing diabetes - 30 days ago STAT+: Alnylam’s twice-a-year drug lowered blood pressure when combined with common pills - 5 months ago STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound - 7 months ago Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound - 11 months ago STAT+: Our expensive obesity drugs are worth it, Novo Nordisk and Eli Lilly argue in raft of studies - 11 months ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Orphan Drug Designation to ZMA001 for Pulmonary Arterial Hypertension - about 2 months ago FDA Grants Accelerated Approval for Elafibranor as Treatment of Primary Biliary Cholangitis - 3 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - 6 months ago FDA Approves Zevtera as Antibiotic to Treat 3 New Indications - 6 months ago FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins - 6 months ago FDA Approves 2 Denosumab Biosimilars for All Indications of Reference Products - 7 months ago FDA Approves Berdazimer Topical Gel as First Treatment for Molluscum Contagiosum - 8 months ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - 9 months ago
5	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Pharmalittle: We’re watching positive Zepbound cardiovascular data, a move to take 23andMe private, and more - about 2 months ago
6	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Will the real Ozempic please stand up? Lilly, Novo face uphill counterfeit battle - 3 months ago
7	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Sanofi resolves most Zantac litigation - 6 months ago
8	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market - 6 months ago
9	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	ALS Therapy to Be Pulled From the Market, Drugmaker Says - 6 months ago Alzheimer's Supplements Fail Compared With Generic Drugs - 7 months ago
10	Joyce Frieden MedPage Today Washington editor at MedPage Today. Board member at AHCJ. Greater Washington, DC area Healthcare journalism	FDA OKs Injectable Antibiotic for Three Different Uses - 6 months ago

Journalists covering Generic Zyloprim